bromperidol has been researched along with Koch's Disease in 1 studies
bromperidol: bromine-substituted for chlorine in haloperidol; RN given refers to unlabeled parent cpd; structure
Excerpt | Relevance | Reference |
---|---|---|
"Spectinomycin was used to test the concept that clinically available antibiotics with limited efficacy against Mycobacterium tuberculosis might be used for TB treatment when coadministered with a synergistic partner compound used as a sensitizer." | 1.37 | Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen. ( Anderson, H; Av-Gay, Y; Chao, JD; Ng, C; Pfeifer, T; Ramón-García, S; Roberge, M; Thompson, CJ; Zheng, X, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ramón-García, S | 1 |
Ng, C | 1 |
Anderson, H | 1 |
Chao, JD | 1 |
Zheng, X | 1 |
Pfeifer, T | 1 |
Av-Gay, Y | 1 |
Roberge, M | 1 |
Thompson, CJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Beta-Lactam Containing Regimen for the Shortening of Buruli Ulcer Disease Therapy: Comparison of 8 Weeks Standard Therapy (Rifampicin Plus Clarithromycin) vs. 4 Weeks Standard Plus Amoxicillin/Clavulanate Therapy [RC8 vs. RCA4][NCT05169554] | Phase 2 | 140 participants (Anticipated) | Interventional | 2021-12-01 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for bromperidol and Koch's Disease
Article | Year |
---|---|
Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen.
Topics: Antitubercular Agents; Drug Synergism; Drug Therapy, Combination; Haloperidol; High-Throughput Scree | 2011 |